OJU.F - Discussions, and Blogs for ORAMED PHARMA

USA

Wealth Management Collaboration Platform

Community Market ScreenersInvestor LandscapeEfficient FrontierCorrelation CloudRisk/ReturnTour

US Market Open: Jan 7, 2009 15:55 PM EST

Processing
Collecting necessary data for OJU...

0.27

^0.03

12.50%

ORAMED PHARMA

OJU

FRANKF

Year Low 0.146 Year High 0.59 Open 0.393 High 0.288 Low 0.288 Last Close 0.27 Volume 12000

{Name}

{Date}

{Time}

{Text}

{Label:Like this comment?} [{Label:yes}] [{Label:no}] ({Label:Score}: 0{Label:byVotes} 0)

{Label:Mark as} [{Label:offensive}]

{Label:leaveComment}

{Label:nameLabel}

{Label:emailLabel}

{Label:emailNote}

{Label:ratingLabel}

{Label:commentLabel}

target: 2.15. wkn : a0j3fg isin : us68403p1049 we are predicting amazing gains on this one! be part of it! add it to your portfolio! watch oju.f on friday april 27th!" from: matteson@autothailand.org directly to: my spam folder ...

01/07/2009

View Post

This Frankfurt Stock Is Going Through The Roof! Company: Oramed Pharma Symbol: OJU.F Price: 0.65 Target: 2.15 Wkn : A0J3FG Isin : US68403P1049. We Are Predicting Amazing Gains On This One! Be Part Of It! Add It To Your Portfolio! ...

01/07/2009

View Post

Watch the latest videos on YouTube.com

T (3pm UK time, 10am EST) today , HAMBURG, Germany...kfurt Stock Exchange: EVT) announced today positiv...l trial of EVT 201 in,patients with chronic primar... Other Medicine Technology:Merck at ASCO 2007: New Data Demonstrate the Value ...

01/07/2009

View Post

Oramed Pharmaceuticals Partners With ETI Karle Clinical To Conduct Phase 2B Trials On Its Oral Insulin Capsule, ORMD 0801, 10 Sept 2008. American Diabetes Association Survey Identifies Issues Every Man With Diabetes Should Know ...

01/07/2009

View Post

oramed pharmaceuticals, inc. (ormp) has successfully completed its exploratory phase 1a clinical trial with it?s oral insulin gel capsule as a replacement for insulin injections. the trial examined changes in insulin, ...

01/07/2009

View Post

Additionally Oramed was one of six companies chosen to be featured in...,Israel's,Prestigious,President's,Conference,to,Feature,Oramed,Pharmaceuticals',Revolutionary,Oral,Insulin,Capsule,biological,advanced biology technology,biology ...

01/07/2009

View Post

insulin oral gel capsule, (diabetes), oramed ? trodusquemine, (obesity), ganaera. about this quarterly report. data for this report was compiled and analyzed using thomson pharma�, a comprehensive global pharmaceutical information ...

01/07/2009

View Post

Volatility

8.37

13 %

of total potential

Expected Return

-1.37

1 %

of total potential

Risk-Adjusted Return

-0.16

1 %

of total potential

Based on monthly moving average [ change assumptions ]

Increase Risk-Adjusted return of OJU.F by adding it to a well-diversified portfolio

Diversify

Compare To...

ESTAVIS FUKUYAMA Eckert AJINOMOTO NIPPON PARAMOUNT CYTOTOOLS Scanfil FAMILYMART YUSEN KISSEI PETROLEO SOFTBANK JAPAN BEST EFG NBH DRAEGERW OIE SANGYO M'BISHI Evraz BASHNEFT CTR ENER

Risk & Return

Correlation

Follow ORAMED using RSS feed